.
Interested parties are invited to attend the seminar "Cancer Research"
Conferences, workshops
Research
On 9 June, Rīga Stradiņš University (RSU) will host a joint workshop, Cancer Research, within the framework of the Latvian–Ukrainian Joint Programme Project Genetic characterization of high-risk human papillomaviruses in Ukraine and Latvia to inform national policy of cervical cancer prevention ( LV_UA/2026/3).
All interested participants are welcome to join the workshop. No prior registration is needed. However, if you plan to join via Zoom, there will be a waiting room. To enter, you will have to identify yourself with your name and surname.Join the seminar on Zoom
Seminārs notiks angļu valodā.
Agenda
| 11.00–11.10 | Opening remarks |
| 11.10–11.30 | Analysis of HPV16 genomes from patients with cervical precancer and cancer followed up in Riga during 2016–2024 Maria Isaguliants, RSU Institute of Microbiology and Virology, Latvia |
| 11.30–11.40 | Phylogenetic analysis of the high-risk human papilloma virus genomes resolved in the frame of LV-UA project Sviataslau Sasinovich, RSU Institute of Microbiology and Virology, Latvia |
| 11.40–11.50 | Parameters of high-risk human papilloma virus infection shaping the severity of disease in cervical precancer and cancer Austra Breiksa, Pauls Stradiņš Clinical University Hospital, Latvia |
| 11.50–12.00 | Immunohistochemical analysis of Ki-67 expression in cervical cancer: pathologist scoring versus automated quantification using QuPath Marija Nazarenko, RSU Institute of Microbiology and Virology, Latvia |
| 12.00–12.20 | Identification of clinically relevant gene variants in brain tumor tissue by cancer hotspot panel Elena Kashuba, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Ukraine |
| 12.20–12.30 | High risk human papilloma virus genotypes identified in tumoral and peritumoral tissues of patients with cervical cancer Larysa Kovalevska, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Ukraine |
| 12.30–12.40 | The effect of IL-2 on expression of STAT transcription factors in B-cells in B-cell Chronic Lymphocytic Leukemia (CLL) Sofia Lytvyn, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Ukraine |
| 12.40–13.00 | A neural network model delivers a highly prognostic protein signature in cancer stem cells that identifies relapse in stage III colorectal cancer patients Mohammadreza Azimi, RSU Institute of Microbiology and Virology, Latvia |
| 13.00–13.15 | Discussion |
